Publications by authors named "Julie R Howle"

Claim this Profile
L
Longitudinal Analysis Reveals Dynamic Changes in Histopathologic Features in Responders to Neoadjuvant Treatment in a Stage III BRAF-Mutant Melanoma Cohort.
Jorja Braden, Alison Potter, Robert V Rawson, Nurudeen A Adegoke, Serigne N Lo, Julie R Howle

Mod Pathol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does preoperative imaging for scalp non-melanocytic skin cancer accurately predict invasion of the cranial vault? A systematic review and meta-analysis.
Benjamin M Rowse, Ann C X Yu, Harrison Faulkner, Gideon Sandler, Julie R Howle

ANZ J Surg· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Has the advent of modern adjuvant systemic therapy for melanoma rendered sentinel node biopsy unnecessary?
Alexander H R Varey, John F Thompson, Julie R Howle, Serigne N Lo, Sydney Ch'ng

Eur J Cancer· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy in advanced cutaneous squamous cell carcinoma: Sydney west cancer network experience.
Shaheen Hasmat, Julie R Howle, Matteo S Carlino, Puma Sundaresan, Michael J Veness

ANZ J Surg· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Merkel cell carcinoma in situ: A systematic review of prognosis and management.
Kelvin Truong, Simone M Goldinger, Shaun Chou, Julie R Howle, Michael J Veness

Australas J Dermatol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRAF mutation testing for patients diagnosed with stage III or stage IV melanoma: practical guidance for the Australian setting.
Richard A Scolyer, Victoria Atkinson, David E Gyorki, Duncan Lambie, Sandra O'Toole, Julie R Howle

Pathology· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Melanoma management in the 21st century: a change in paradigm.
Julie R Howle, Alexander H R Varey, Matteo S Carlino

ANZ J Surg· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy in advanced Merkel cell carcinoma: Sydney west cancer network experience.
Shaheen Hasmat, Julie R Howle, Deme J Karikios, Matteo S Carlino, Michael J Veness

J Med Imaging Radiat Oncol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival Outcomes of Salvage Metastasectomy After Failure of Modern-Era Systemic Therapy for Melanoma.
Andrew T Li, Kavita Vakharia, Serigne N Lo, Alexander H R Varey, Matteo S Carlino, Julie R Howle

Ann Surg Oncol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of patients with metastatic cutaneous squamous cell carcinoma to the axilla: a multicentre cohort study.
Phillip F Yang, Michael J Veness, Edward A Cooper, Richard Fox, Robert I Smee, Julie R Howle

ANZ J Surg· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and Testing of a Custom Melanoma Next Generation Sequencing Panel for Analysis of Circulating Tumor DNA.
Russell J Diefenbach, Jenny H Lee, Alexander M Menzies, Matteo S Carlino, Georgina V Long, Julie R Howle

Cancers (Basel)· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sentinel lymph node biopsy in clinically node-negative Merkel cell carcinoma: the Westmead Hospital experience.
Lillian N Jenkins, Julie R Howle, Michael J Veness

ANZ J Surg· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-L1 Expression and Immune Escape in Melanoma Resistance to MAPK Inhibitors.
Hojabr Kakavand, Robert V Rawson, Gulietta M Pupo, Jean Y H Yang, Alexander M Menzies, Julie R Howle

Clin Cancer Res· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamic Changes in PD-L1 Expression and Immune Infiltrates Early During Treatment Predict Response to PD-1 Blockade in Melanoma.
Ricardo E Vilain, Alexander M Menzies, James S Wilmott, Hojabr Kakavand, Jason Madore, Julie R Howle

Clin Cancer Res· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Definitive radiotherapy for Merkel cell carcinoma confers clinically meaningful in-field locoregional control: A review and analysis of the literature.
Dakshika A Gunaratne, Julie R Howle, Michael J Veness

J Am Acad Dermatol· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Merkel cell carcinoma: A case of palliative upper limb amputation in a patient with refractory in-transit metastases.
Dakshika A Gunaratne, Julie R Howle, Michael J Veness

Australas J Dermatol· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome of patients with microscopic and macroscopic metastatic nodal Merkel cell carcinoma: an Australian experience.
Julie R Howle, Michael J Veness

Dermatol Surg· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intratumoral molecular heterogeneity in a BRAF-mutant, BRAF inhibitor-resistant melanoma: a case illustrating the challenges for personalized medicine.
James S Wilmott, Varsha Tembe, Julie R Howle, Raghwa Sharma, John F Thompson

Mol Cancer Ther· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Merkel cell carcinoma: an Australian perspective and the importance of addressing the regional lymph nodes in clinically node-negative patients.
Julie R Howle, T Michael Hughes, Val Gebski, Michael J Veness

J Am Acad Dermatol· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plexiform fibrohistiocytic tumour: morphological changes and challenges in assessment of recurrent and metastatic lesions.
Kyaw Lynnhtun, Anita Achan, Meena Shingde, Shaun Chou, Julie Riina Howle

Histopathology· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distinguishing clinicopathologic features of patients with V600E and V600K BRAF-mutant metastatic melanoma.
Alexander M Menzies, Lauren E Haydu, Lydia Visintin, Matteo S Carlino, Julie R Howle

Clin Cancer Res· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective BRAF inhibitors induce marked T-cell infiltration into human metastatic melanoma.
James S Wilmott, Georgina V Long, Julie R Howle, Lauren E Haydu, Raghwa N Sharma

Clin Cancer Res· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Merkel cell carcinoma metastatic to the transverse colon: disease free after six years - cure or just prolonged remission?
Michael J Veness, Julie R Howle

Australas J Dermatol· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metastatic cutaneous squamous cell carcinoma of the scalp.
Julie R Howle, Gary J Morgan, Inars Kalnins, Carsten E Palme, Michael J Veness

ANZ J Surg· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis